A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid‐β oligomers.
J Neurochem; doi: 10.1111/jnc.14118.
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
BioMed Central; 10.1186/s13024-017-0173-0.
In vitro study on potential pharmacological activity of curcumin analogues and their copper complexes
Chem Biol Drug Des.; doi: 10.1111/cbdd.12847.
Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
Mediators of Inflammation; https://doi.org/10.1155/2017/6209865.
An UHPLC–MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
J Chromatogr B Analyt Technol Biomed Life Sci.; doi: 10.1016/j.jchromb.2017.10.047.
Synthesis and evaluation of benzothiazole-triazole and benzothiadiazole-triazole scaffolds as potential molecular probes for amyloid-β aggregation.
New Journal of Chemistry; DOI: 10.1039/C6NJ01703G.
Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease
Nanomedicine: Nanotechnology, Biology and Medicine; doi: 10.1016/j.nano.2017.06.013
Tuning the stereo-hindrance of a curcumin scaffold for the selective imaging of the soluble forms of amyloid beta species.
Chemical Science; DOI:10.1039/C7SC02050C.
Identification of dibenzyl imidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells.
Science Direct European Journal of Medicinal Chemistry; http://dx.doi.org/10.1016/j.ejmech.2017.02.057.
Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery.
Clinical Interventions in Aging; doi: 10.2147/CIA.S134605